1. Home
  2. IOVA vs DV Comparison

IOVA vs DV Comparison

Compare IOVA & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.91

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo DoubleVerify Holdings Inc.

DV

DoubleVerify Holdings Inc.

HOLD

Current Price

$10.95

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
DV
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
IOVA
DV
Price
$4.91
$10.95
Analyst Decision
Buy
Buy
Analyst Count
10
15
Target Price
$9.00
$16.37
AVG Volume (30 Days)
16.3M
2.2M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
14.84
N/A
EPS
N/A
0.04
Revenue
N/A
$748,291,000.00
Revenue This Year
$47.74
$12.68
Revenue Next Year
$40.31
$9.75
P/E Ratio
N/A
$264.00
Revenue Growth
N/A
13.92
52 Week Low
$1.76
$7.61
52 Week High
$5.64
$16.82

Technical Indicators

Market Signals
Indicator
IOVA
DV
Relative Strength Index (RSI) 60.02 50.91
Support Level $3.77 $10.76
Resistance Level $5.63 $11.60
Average True Range (ATR) 0.40 0.43
MACD 0.05 -0.14
Stochastic Oscillator 68.35 43.64

Price Performance

Historical Comparison
IOVA
DV

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a media effectiveness platform that leverages artificial intelligence (AI) to drive superior outcomes for international brands by creating transparent ad transactions. Its solutions provide unbiased data analytics to improve the effectiveness, quality and return on advertising investments. DV Authentic Ad is its proprietary metric measuring whether an ad was delivered in a brand suitable environment, fully viewable, by a real person and in geography, while DV Pinnacle delivers these metrics in real time. The Company's solutions are integrated across programmatic platforms, social media channels and digital publishers, and are accredited by the Media Rating Council for digital ad measurement. It operates in the United States and international markets.

Share on Social Networks: